Science News

Drug updates and approvals: 2018 in review.

A new interesting article has been published in Nurse Pract. 2018 Dec;43(12):23-32. doi: 10.1097/01.NPR.0000547548.63764.6b. and titled:

Drug updates and approvals: 2018 in review.

Authors of this article are:

Mospan C, Mospan G, Byland E, Whitaker WB, Xiong L, Dunlap J, Canupp K.

A summary of the article is shown below:

In 2018, the FDA approved several new drugs for use in primary care. This article highlights the following new drugs: bictegravir, emtricitabine, and tenofovir alafenamide (Biktarvy); doxylamine succinate and pyridoxine hydrochloride (Bonjesta); erenumab-aooe (Aimovig); lofexidine hydrochloride (Lucemyra); tezacaftor and ivacaftor (Symdeko); and tildrakizumab-asmn (Ilumya).

Check out the article’s website on Pubmed for more information:



This article is a good source of information and a good way to become familiar with topics such as:

n/a

.

Categories: Science News